The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: a case report.
Int J Infect Dis. 2018 Sep 19;:
Authors: Park S, Lee KM, Kim I, Mok J
The use of bedaquiline to treat multidrug-resistant tuberculosis (MDR-TB) patients with end-stage renal disease (ESRD) may raise safety concerns. Currently, however, no clinical information is available on the use of bedaquiline to treat MDR-TB patients with ESRD. We report the use of bedaquiline to treat two patients with MDR-TB and ESRD. Our case report highlights the safety and tolerability of bedaquiline as well as the treatment outcome. The use of bedaquiline in patients with ESRD is also discussed.
PMID: 30244076 [PubMed - as supplied by publisher]